BOIRON |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.7 EUR | +0.58% |
|
+1.17% | -13.72% |
| Feb. 02 | Boiron: nearly 600,000 shares tendered to the OPAS | CF |
| Jan. 11 | Boiron: OPAS open from January 11 to 31 | CF |
Business Summary
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
Number of employees: 2,813
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Homeopathic Specialties
57.0
%
| 280 | 52.4 % | 281 | 57.0 % | +0.47% |
Common Name Homeopathic Medicines
36.0
%
| 185 | 34.6 % | 178 | 36.0 % | -3.76% |
Other Health Products
7.0
%
| 70 | 13.1 % | 34 | 7.0 % | -50.63% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
France
47.9
%
| 280 | 52.4 % | 236 | 47.9 % | -15.65% |
Europe
24.7
%
| 120 | 22.5 % | 122 | 24.7 % | +1.17% |
North America
24.4
%
| 121 | 22.6 % | 120 | 24.4 % | -0.10% |
Other Countries
3.0
%
| 13 | 2.5 % | 15 | 3.0 % | +11.75% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 11-06-30 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hervé Coulpier
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Patrice Varraut
COO | Chief Operating Officer | - | 08-12-31 |
Fabrice Rey
IRC | Investor Relations Contact | - | - |
Juliette Baudry
HRO | Human Resources Officer | - | - |
Frédéric Ducher
LAW | General Counsel | - | 15-05-31 |
Eric Lambert
SEC | Corporate Secretary | - | 19-05-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 80 | 03-05-21 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Philippe Brun
BRD | Director/Board Member | 64 | 21-05-26 |
Michéle Boiron
BRD | Director/Board Member | 79 | 96-09-17 |
| Director/Board Member | 52 | 10-03-09 | |
Anne Borfiga
BRD | Director/Board Member | 52 | 21-05-26 |
| Director/Board Member | 49 | 13-05-22 | |
| Corporate Officer/Principal | 61 | 15-12-31 | |
Laurence Boiron
BRD | Director/Board Member | 49 | 20-05-27 |
Sylvain Mossaz
BRD | Director/Board Member | 48 | 20-12-16 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 17,545,408 | 2,265,995 ( 12.92 %) | 183,133 ( 1.044 %) | 12.92 % |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Boiron Laboratories Pvt Ltd.
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
34.5
EUR
Average target price
39.6
EUR
Spread / Average Target
+14.78%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.22% | 645M | |
| +43.35% | 6.32B | |
| -15.99% | 4.49B | |
| -6.35% | 3.3B | |
| +4.87% | 3.19B | |
| -0.53% | 2.6B | |
| +53.07% | 2.05B | |
| -3.63% | 1.77B | |
| +2.76% | 1.7B | |
| -8.02% | 1.63B |
- Stock Market
- Equities
- BOI Stock
- Company BOIRON